In a follow-up to a news report on a Hungarian scientist who was accidentally exposed to Ebola virus,  health authorities (computer translated) say the scientist was exposed on April 13  at the National...

Emergex Vaccines Holding Limited (Emergex), a private biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, today provides an update on its vaccine...

Yesterday, GeoVax Labs, Inc. announced the publication of its manuscript entitled “A Single-Dose of Modified Vaccinia Ankara Expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal...

University of Hawaii vaccine researcher Axel Lehrer, PhD, has received a nearly $6.3 million grant to test whether the Ebola vaccine formula he has developed will protect against two additional viruses...

A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants...

The end of a year gives us an opportunity to reflect on the year that was and make lists of things that made an impact in our lives. The positive impact of vaccines on the lives of individuals and families...

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published Thursday in The Lancet. The vaccine is the first to prevent infection...

An Ebola vaccine will take the next critical steps in development under a $24.75 million contract through May 2020 between the U.S. Department of Health and Human Services’ Office of the Assistant...

An immunization regimen using two Ebola vaccine candidates was safe and well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are...

WHO’s office in Guinea says more than 1,000 contacts have been identified and placed under medical observation. Nearly 800 have been vaccinated over the past week, including 182 who are considered to...